Abstract
The current practice guideline recommends bleeding risk scores as risk-assessment tool for the management of patients with acute coronary syndrome (ACS) receiving dual antiplatelet therapy (DAPT), but no validated tool exists for Korean patients with a well-known differential propensity for bleeding and ischemic events.1,2 We sought to compare the predictive performance of commonly used bleeding risk scores of the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY),3 Patterns of Non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS),4 and Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT)5 risk scores for bleeding complications in Korean (Korean) patients with ACS receiving DAPT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
